( 02142.hk)
市盈率13.36市净率3.32股息率0%上市时间2020-12-10股价10.60港币涨跌幅-4.16%成交金额4,653.32万港币换手率0.49%市值94.95亿港币H股市值94.95亿港币总股本8.96亿H股本8.96亿每手股数1,000上市至今年化投资收益率-0.67%港股通持仓占H股比例2.25% (2.10亿港币2026-06-03) 累计做空占H股比例4.01% (4.20亿港币2026-05-29)
所属三级行业生物技术 (恒生) 市盈率97.58市净率3.79股息率0.44%恒生:医疗保健业药品及生物科技生物技术
备注 (6): 双击编辑备注
发表讨论

和铂医药-B(02142) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1COLLINSON Albert R.Independent Non Executive Director2023-07-13--
2戎一平Executive Director2022-05-05--
3陳小祥Executive Director2021-09-172022-05-05
4陳維維Non Executive Director2021-06-09--
5邱家賜Independent Non Executive Director2021-06-09--
6葉小平Independent Non Executive Director2020-11-30--
7陳維維Independent Non Executive Director - A/F2020-11-302021-06-09
8DESHPANDE Atul MukundExecutive Director2020-08-102021-04-25
9王俊峰Non Executive Director2018-03-212023-07-13
10廖邁菁Executive Director2018-01-182021-09-17
11KAMEN Robert IrwinIndependent Non Executive Director2016-12-07--
12裘育敏Non Executive Director2016-12-072023-07-13
13王勁松Executive DirectorChairman, CEO2016-07-20--